Cytokinetics | CYTK - Koszty Sprzedaży I Administracji





Koszty Sprzedaży I Administracji Zmiana Data
Acadia Pharmaceuticals USD 148.57M 12.22M 2026-06
Amgen USD 1.72B 134M 2026-06
Arca Biopharma USD 2.23M 1.08M 2025-12
Bayer EUR 3.96B 267M 2026-06
Biogen USD 752M 42.3M 2026-09
Brainstorm Cell Therapeutics USD 1.21M 178K 2026-03
Bristol-Myers Squibb USD 1.7B 127M 2026-09
Capricor Therapeutics USD 1.92M 446.47K 2025-12
Cytokinetics USD 104.4M 499K 2026-06
Eisai JPY 114.83B 4.71B 2026-06
Eli Lilly USD 3.12B 305M 2026-09
Exelixis USD 154.56M 6.93M 2026-09
Geron USD 35.42M 6.24M 2026-03
Halozyme Therapeutics USD 57M 10.71M 2026-06
Ionis Pharmaceuticals USD 130.07M 20.92M 2026-06
Ligand Pharmaceuticals USD 72.62M 43.49M 2026-09
Merck USD 2.86B 25M 2026-09
Novartis USD 3.08B 163M 2026-09
Pfizer USD 3.41B 496M 2026-06
Regeneron Pharmaceuticals USD 662.1M 14.4M 2026-06
Roche Holding CHF 6.37B 908M 2026-06
Sanofi EUR 2.31B 325M 2026-09